硬皮病特异性自身抗体是否应纳入干燥综合征的诊断检查
在216例因干燥症状转诊的患者中,41.7%(90/216)检出硬皮病特异性自身抗体,强滴度者占19%,中等滴度者占22.7%。强滴度抗体与符合干燥综合征组织病理学标准的小唾液腺活检阳性独立相关(校正OR 4.1,95%CI 1.5-10.6)。作者认为硬皮病抗体检测在干燥综合征诊断检查中有用,并可能用于分类标准。
要点
- 干燥症状患者中硬皮病特异性自身抗体检出率为41.7%(90/216)。
- 强滴度抗体与符合干燥综合征病理标准的小唾液腺活检阳性独立相关(校正OR 4.1)。
- 抗Ro/SSA阳性与阴性组间硬皮病抗体检出率无显著差异。
核心结论
- 硬皮病特异性自身抗体在干燥症状患者中常见,强滴度而非中等滴度抗体与MSD活检阳性独立相关。
- 作者认为这些数据提示硬皮病抗体检测在干燥综合征诊断检查中有用,并可能用于其分类标准。
研究设计与样本
- 连续纳入216例因干燥症状转诊评估可能干燥综合征的患者,记录人口学、临床病理和实验室数据。
- 所有参与者用商业免疫印迹试剂盒检测针对CENP、PM/Scl、Scl-70、Ku、NOR90、RP11、RP155、fibrillarin、PDGFR和Th/To的硬皮病特异性自身抗体。
- 根据条带强度将检出的自身抗体分为强滴度和中等滴度。
主要发现
- 硬皮病特异性自身抗体总检出率为41.7%(90/216),其中强滴度占19%,中等滴度占22.7%。
- 抗Ro/SSA阳性组与阴性组间硬皮病特异性自身抗体检出率无显著差异。
- 强滴度抗体在符合干燥综合征组织病理学标准的小唾液腺活检患者中显著更高(30% vs 12.5%,p=0.009)。
- 校正抗Ro/SSA和La/SSB自身抗体后,强滴度抗体与小唾液腺活检阳性的关联仍显著(OR 4.1,95%CI 1.5-10.6)。
关键数值与推荐
- 强滴度硬皮病特异性自身抗体与MSD活检阳性的校正OR为4.1(95%CI 1.5-10.6)。
- MSD活检符合干燥综合征组织病理学标准的患者中强滴度抗体阳性率为30%,不符合者为12.5%(p=0.009)。
临床怎么用
- 作者认为硬皮病抗体检测在干燥综合征诊断检查中有用,并可能用于其分类标准。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Sicca complaints are a frequent reason for rheumatologic consultation. Testing for specific antibodies against Ro/SSA and La/SSB antigens and minor salivary gland (MSG) biopsy are among the main tools implemented in the diagnostic work-up. Anticentromere antibodies and sicca manifestations are frequently detected in Sjögren's syndrome (SS) and systemic sclerosis (SSc), respectively. Herein, we aimed to determine the frequency and clinical associations of a wide spectrum of scleroderma (SSc)-specific autoantibodies in consecutive patients referred for evaluation of possible SS. METHODS: Demographic, clinico-pathological, and laboratory data were recorded in 216 consecutive patients with sicca complaints. All study participants were tested for SSc-specific autoantibodies (against CENP, PM/Scl, Scl-70, Ku, NOR90, RP11, RP155, fibrillarin, PDGFR, and Th/To) using a commercially available immunoblot kit. According to band intensity, the identified autoantibodies were further classified in those with strong and medium titers. RESULTS: SSc-specific autoantibodies were detected in 41.7% (90/216) patients evaluated (19% at strong, 22.7% at medium titers) without significant differences between anti-Ro/SSA positive and negative groups. At strong titers was significantly higher in patients with MSG biopsies fulfilling SS histopathological criteria (30% vs 12.5%, p = 0.009). This association remained significant after adjustment for antibodies against Ro/SSA and La/SSB autoantigens [OR 95% (CI): 4.1 (1.5-10.6)]. CONCLUSION: SSc-specific autoantibodies are frequently detected among patients presenting with sicca complaints and at strong but not medium titers are independently associated with MSG biopsy positivity. Taken together, these data imply a useful role of SSc antibody testing in the diagnostic work-up and possibly in the classification criteria for SS.
引用
- Marketos N, Koulouri V, Piperi EP, et al. Scleroderma-specific autoantibodies: Should they be included in the diagnostic work-up for Sjögren's syndrome? Semin Arthritis Rheum. 2022. PMID: 35623241. doi:10.1016/j.semarthrit.2022.152026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。